Inhibition of Glycogen Phosphorylase in the Context of Type 2 Diabetes, with Focus on Recent Inhibitors Bound at the Active Site

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|10|12|1102-1126

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.10, Iss.12, 2010-10, pp. : 1102-1126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus

By Treadway J.L.   Mendys P.   Hoover D.J.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 3, 2001-03 ,pp. : 439-454

Informa Healthcare

Access to resources Recommend Favorite

Glycogen Phosphorylase as a Target for Type 2 Diabetes: Synthetic, Biochemical, Structural and Computational Evaluation of Novel N-acyl-N´-(&bgr;-D-glucopyranosyl) Urea Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 23, 2015-01 ,pp. : 2373-2389

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Allosteric Inhibition of Glycogen Phosphorylase

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 12, 2010-10 ,pp. : 1139-1155

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Phosphorylase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 845-857

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen phosphorylase inhibition as a therapeutic target: a review of the recent patent literature

By Baker David J   Greenhaff Paul L   Timmons James A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 459-466

Informa Healthcare

Access to resources Recommend Favorite